HELICOBACTER PYLORI INFECTIONS

This study looked at 508 adults with H. pylori infection to see if a 7-day triple therapy (using vonoprazan, amoxicillin, and tetracycline) works as well as the standard 14-day dual therapy (vonoprazan and amoxicillin). Researchers compared how often the infection was cleared and…

This study looked at whether treating Helicobacter pylori (a common stomach infection) can improve platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, raising bleeding risk. Researchers tested 100 Iraqi adults with…

This study looked back at medical records of 3000 people treated for H. pylori infection to see how often treatment actually works outside of controlled trials. Researchers collected data on which treatments were used and what factors, like antibiotic resistance or patient habits…

This study analyzed health records from over 5,200 adults to see if people with an H. pylori infection (a common stomach bug) are more likely to have metabolic syndrome—a cluster of conditions like high blood pressure, high blood sugar, and extra belly fat. Researchers compared H…

This study checked if a new generic version of the stomach acid drug vonoprazan works the same as the brand-name drug Voquezna. Twenty-eight healthy adults took a single dose of each version under fasting conditions. The results showed the generic tablet was bioequivalent, meanin…

This study looked at 7,227 patients in Nanjing to understand how resistant the H. pylori bacteria is to common antibiotics. The goal was to find out which antibiotics still work best and to help doctors choose the right treatment for each patient. No new treatments were tested; i…